Michael T Kelliher
Overview
Explore the profile of Michael T Kelliher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walsh M, Kelliher M, Hubbard J, Cervinski M
J Appl Lab Med
. 2025 Feb;
PMID: 39903694
Background: Immunoassay drug screens provide rapid analysis of urine for the presence of therapeutics and drugs of abuse. Compared to definitive (confirmatory) methods, immunoassays are prone to false-positive and -negative...
2.
Alvarez Y, Kelliher M, Hubbard J, Nerenz R, Cervinski M
J Appl Lab Med
. 2022 Jul;
7(5):1151-1157.
PMID: 35899580
Background: The aim of this study was to redefine the icterus index cutoff for the Roche Jaffé creatinine method using both conjugated and unconjugated bilirubin on 3 Roche cobas modules...
3.
Kelliher M, Levy J, Nerenz R, Poore B, Johnston A, Rogers A, et al.
Arch Pathol Lab Med
. 2022 Feb;
146(6):677-685.
PMID: 35188563
Context.—: Moderna (mRNA-1272) and Pfizer (BNT162b2) SARS-CoV-2 vaccines demonstrate favorable safety and efficacy profiles, but direct comparison data are lacking. Objective.—: To determine the vaccines' side effect profiles and expected...
4.
Poore B, Hamilton R, Kelliher M, Mahmood S, Mindiola-Romero A, Richards R, et al.
J Appl Lab Med
. 2022 Jan;
7(1):36-45.
PMID: 34996088
Background: Autoimmune encephalitis (AE) is a rare collection of disorders that present with a diverse and often nebulous set of clinical symptoms. Indiscriminate use of multi-antibody panels decreases their overall...
5.
Javanbakht A, Kelliher M, Poore B, Harris V, Cervinski M
Clin Chem
. 2021 Jul;
67(7):1037-1038.
PMID: 34229341
No abstract available.
6.
Kelliher M, Saunders H, Wildonger J
Curr Opin Neurobiol
. 2019 Feb;
57:39-45.
PMID: 30738328
Neurons are exquisitely polarized cells whose structure and function relies on microtubules. Microtubules in signal-receiving dendrites and signal-sending axons differ in their organization and microtubule-associated proteins. These differences, coupled with...
7.
Kelliher M, Yue Y, Ng A, Kamiyama D, Huang B, Verhey K, et al.
J Cell Biol
. 2018 May;
217(7):2531-2547.
PMID: 29728423
Neuronal polarity relies on the selective localization of cargo to axons or dendrites. The molecular motor kinesin-1 moves cargo into axons but is also active in dendrites. This raises the...
8.
Winding M, Kelliher M, Lu W, Wildonger J, Gelfand V
Proc Natl Acad Sci U S A
. 2016 Aug;
113(34):E4985-94.
PMID: 27512046
The plus-end microtubule (MT) motor kinesin-1 is essential for normal development, with key roles in the nervous system. Kinesin-1 drives axonal transport of membrane cargoes to fulfill the metabolic needs...
9.
Piraino M, Kelliher M, Aburas J, Southern C
Immunol Lett
. 2015 Jun;
167(1):29-33.
PMID: 26112419
The bacterial enzyme EndoS specifically cleaves glycans bound to immunoglobulin G (IgG) molecules. Because this deglycosylation procedure leads to a diminished immune response, this enzyme has potential applications as a...
10.
Kelliher M, Jacks R, Piraino M, Southern C
Mol Immunol
. 2014 May;
60(2):103-8.
PMID: 24813166
The deglycosylation of immunoglobulin G (IgG) antibodies leads to a diminished immune response. This reduction in immune response is thought to arise from weakened binding of IgG antibodies to effector...